JPH11508768A5 - - Google Patents

Info

Publication number
JPH11508768A5
JPH11508768A5 JP1997504165A JP50416597A JPH11508768A5 JP H11508768 A5 JPH11508768 A5 JP H11508768A5 JP 1997504165 A JP1997504165 A JP 1997504165A JP 50416597 A JP50416597 A JP 50416597A JP H11508768 A5 JPH11508768 A5 JP H11508768A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997504165A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11508768A (ja
JP4119952B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1996/002748 external-priority patent/WO1997001357A1/en
Publication of JPH11508768A publication Critical patent/JPH11508768A/ja
Publication of JPH11508768A5 publication Critical patent/JPH11508768A5/ja
Application granted granted Critical
Publication of JP4119952B2 publication Critical patent/JP4119952B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP50416597A 1995-06-27 1996-06-24 ウイルス粒子産生カプセル化細胞 Expired - Lifetime JP4119952B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK0740/95 1995-06-27
DK74095 1995-06-27
PCT/EP1996/002748 WO1997001357A1 (en) 1995-06-27 1996-06-24 Encapsulated cells producing viral particles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007301109A Division JP4848348B2 (ja) 1995-06-27 2007-11-21 ウイルス粒子産生カプセル化細胞

Publications (3)

Publication Number Publication Date
JPH11508768A JPH11508768A (ja) 1999-08-03
JPH11508768A5 true JPH11508768A5 (2) 2004-08-19
JP4119952B2 JP4119952B2 (ja) 2008-07-16

Family

ID=8097001

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50416597A Expired - Lifetime JP4119952B2 (ja) 1995-06-27 1996-06-24 ウイルス粒子産生カプセル化細胞
JP2007301109A Expired - Lifetime JP4848348B2 (ja) 1995-06-27 2007-11-21 ウイルス粒子産生カプセル化細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007301109A Expired - Lifetime JP4848348B2 (ja) 1995-06-27 2007-11-21 ウイルス粒子産生カプセル化細胞

Country Status (21)

Country Link
US (1) US6776985B1 (2)
EP (1) EP0835137B1 (2)
JP (2) JP4119952B2 (2)
KR (1) KR100484883B1 (2)
CN (1) CN1187095C (2)
AT (1) ATE309000T1 (2)
AU (1) AU708273B2 (2)
CA (1) CA2222559A1 (2)
CZ (1) CZ286979B6 (2)
DE (1) DE69633180D1 (2)
DK (1) DK0835137T3 (2)
ES (1) ES2253754T3 (2)
IL (1) IL122119A (2)
NO (1) NO321427B1 (2)
NZ (1) NZ312671A (2)
PL (1) PL185338B1 (2)
PT (1) PT835137E (2)
RU (1) RU2187301C2 (2)
SI (1) SI0835137T1 (2)
UA (1) UA65525C2 (2)
WO (1) WO1997001357A1 (2)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3908274B2 (ja) 1995-03-09 2007-04-25 ゲーエスエフ−フォルシュンクスツェントラム・フュア・ウムベルト・ウント・ゲズントハイト・ゲーエムベーハー 遺伝子治療用の抗菌ペプチドをコードする治療用遺伝子を有するベクター
ATE309000T1 (de) 1995-06-27 2005-11-15 Bavarian Nordic As Verkapselte zellen die virenpartikeln produzieren
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
RU2185821C2 (ru) 1996-03-27 2002-07-27 Бавариан Нордик Рисерч Инститьют А/С Трансдуцирующие цитохром р450 ретровирусные векторы
WO1999056660A1 (en) 1998-05-05 1999-11-11 Koninklijke Philips Electronics N.V. Toothbrush comprising a brush member having a bristle field and an interdental bristle field
AU2005229434B2 (en) 2004-03-30 2010-09-30 Nsgene A/S Therapeutic use of a growth factor, NsG33
JP2008540347A (ja) 2005-05-03 2008-11-20 フェテリネールメディツィニシュ ウニベルジテート ウィーン 浸透性カプセル
CN101903049B (zh) 2007-12-20 2014-08-13 伊西康公司 包囊的肾组织
KR101250925B1 (ko) * 2011-10-28 2013-04-04 한화케미칼 주식회사 캡슐 세포용 구조체
GB201408233D0 (en) 2014-05-09 2014-06-25 Austrianova Singapore Pte Ltd Use of polyanionic composition
FR3044016A1 (fr) * 2015-11-24 2017-05-26 Glaxosmithkline Ip Dev Ltd Lignees cellulaires stables pour la production retrovirale
KR102067352B1 (ko) * 2015-11-24 2020-01-16 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 레트로바이러스 생산을 위한 일시적인 형질감염 방법
US11427809B2 (en) 2016-05-25 2022-08-30 Lonza Houston, Inc. Methods for isolating adeno-associated virus using a polydialkylammonium salt
RU2688383C2 (ru) * 2017-07-10 2019-05-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский национальный исследовательский государственный университет имени Н.Г. Чернышевского" Способ синтеза белка в культуре бактериальных клеток
CA3220737A1 (en) * 2021-05-21 2022-11-24 Bionaut Labs Ltd. System and method for localized therapeutic treatment
CN115820683B (zh) * 2022-09-28 2024-04-05 西南大学 家蚕Cyp9a20基因及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391909A (en) * 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
DD160393A3 (de) * 1980-11-14 1983-07-27 Horst Dautzenberg Mikrokapseln und verfahren zu ihrer herstellung
US4686098A (en) * 1984-05-14 1987-08-11 Merck & Co., Inc. Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo
US4680174A (en) * 1984-05-24 1987-07-14 Damon Biotech, Inc. Induction of immune response by immunization with encapsulated antigen-producing cells
EP0199362A3 (en) * 1985-04-26 1987-10-07 Massachusetts Institute Of Technology System and apparatus for delayed and pulsed release of biologically active substances
CA1310924C (en) * 1986-04-24 1992-12-01 Francis P. Mccormick Infective drug delivery system
WO1989011539A1 (en) 1988-05-17 1989-11-30 Sloan-Kettering Institute For Cancer Research Retroviral vector
US5328470A (en) * 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
DE4021050A1 (de) * 1990-06-29 1992-01-02 Akad Wissenschaften Ddr Verfahren zur herstellung von mikrokapseln
CA2051288C (en) * 1990-09-14 2002-02-05 Robert L. Martuza Viral targeted destruction of neoplastic cells
WO1992010564A1 (en) * 1990-12-13 1992-06-25 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy
WO1994029437A1 (en) 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
US5688773A (en) 1994-08-17 1997-11-18 The General Hospital Corporation Method of selectively destroying neoplastic cells
CA2198210C (en) 1994-09-02 2006-07-11 Gsf - Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Non self-inactivating, expression targeted retroviral vectors
ATE309000T1 (de) 1995-06-27 2005-11-15 Bavarian Nordic As Verkapselte zellen die virenpartikeln produzieren
DK0848757T3 (da) 1995-09-06 2002-07-01 Austrian Nordic Biotherapeutic Anvendelse af WAP eller MMTV regulatoriske sekvenser for målrettet ekspression af sammenkædede heterologe gener i humane mammae celler, inklusiv humane mammae carcinoma celler
RU2185821C2 (ru) 1996-03-27 2002-07-27 Бавариан Нордик Рисерч Инститьют А/С Трансдуцирующие цитохром р450 ретровирусные векторы

Similar Documents

Publication Publication Date Title
JP2000500440A5 (2)
JP2000500228A5 (2)
JP2000500445A5 (2)
JPH11515116A5 (2)
JP2000500327A5 (2)
JPH11512012A5 (2)
JPH11507873A5 (2)
JP2000500145A5 (2)
JP2000500155A5 (2)
JP2000500361A5 (2)
JPH11508742A5 (2)
JP2000500115A5 (2)
JP2001518000A5 (2)
JPH11509688A5 (2)
JP2000500322A5 (2)
JP2000500258A5 (2)
JPH11507763A5 (2)
JP2000500342A5 (2)
JP2000500226A5 (2)
JP2000500051A5 (2)
JP2000500166A5 (2)
JP2000500397A5 (2)
JP2000500407A5 (2)
JP2000500019A5 (2)
JPH11513826A5 (2)